Nifurtoinol
From Wikipedia, the free encyclopedia
 |
|
|
Nifurtoinol
|
|
| Systematic (IUPAC) name | |
| 3-(hydroxymethyl)-1-{[(1E)-(5-nitro-2-furyl) methylene]amino}imidazolidine-2,4-dione |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C9H8N4O6 |
| Mol. mass | 268.183 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | Renal (40–50% within the first 12 hours) |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Nifurtoinol (rINN, trade name Urfadyn) is a nitrofuran-derivative antibiotic used in the treatment of urinary tract infections.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||
